Elanco Animal Health (ELAN) Misses Q4 EPS by 1c, provides guidance

Elanco Animal Health (NYSE: ELAN) reported Q4 EPS of $0.14, $0.01 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $1.02 billion versus the consensus estimate of $1.01 billion.

GUIDANCE:

Elanco Animal Health sees FY2025 EPS of $0.80-$0.86, versus the consensus of $0.90. Elanco Animal Health sees FY2025 revenue of $4.445-4.51 billion, versus the consensus of $4.534 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Can Anthropic actually match or beat SpaceX’s IPO? Numbers say "Yes, but"
• Cummins (CMI) PT Lowered to $675 at Jefferies